Log in to save to my catalogue

Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via de...

Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via de...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2476739086

Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA

About this item

Full title

Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA

Publisher

London: Nature Publishing Group UK

Journal title

Oncogene, 2020-11, Vol.39 (47), p.7051-7062

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Multiple RNA processing events including transcription, mRNA splicing, and export are delicately coordinated by the TREX complex. As one of the essential subunits, DDX39B couples the splicing and export machineries by recruiting ALYREF onto mRNA. In this study, we further explore the functions of DDX39B in handling damaged DNA, and unexpectedly fin...

Alternative Titles

Full title

Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2476739086

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2476739086

Other Identifiers

ISSN

0950-9232

E-ISSN

1476-5594

DOI

10.1038/s41388-020-01482-x

How to access this item